Cargando…

Methylphenidate and galantamine in patients with vascular cognitive impairment–the proof-of-principle study STREAM-VCI

BACKGROUND: To date, no symptomatic treatment is available for patients with vascular cognitive impairment (VCI). In the proof-of-principle study Symptomatic Treatment of Vascular Cognitive Impairment (STREAM-VCI), we investigated whether a single dose of a monoaminergic drug (methylphenidate) impro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leijenaar, Jolien F., Groeneveld, Geert Jan, Klaassen, Erica S., Leeuwis, Anna E., Scheltens, Philip, Weinstein, Henry C., van Gerven, Joop M. A., Barkhof, Frederik, van der Flier, Wiesje M., Prins, Niels D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947990/ https://www.ncbi.nlm.nih.gov/pubmed/31910895 http://dx.doi.org/10.1186/s13195-019-0567-z

Ejemplares similares

Decreased integrity of the monoaminergic tract is associated with a positive response to MPH in patients with vascular cognitive impairment - proof of principle study STREAM-VCI
por: Leijenaar, Jolene F, et al.
Publicado: (2022)

Symptomatic Treatment of Vascular Cognitive Impairment (STREAM-VCI): Protocol for a Cross-Over Trial
por: Leijenaar, Jolien Fleur, et al.
Publicado: (2018)

Prediction of poor clinical outcome in vascular cognitive impairment: TRACE‐VCI study
por: Boomsma, Jooske M.F., et al.
Publicado: (2020)

Vascular Cognitive Impairment and cognitive decline; a longitudinal study comparing different types of vascular brain injury - The TRACE-VCI study
por: Boomsma, Jooske MF, et al.
Publicado: (2022)

Vascular Cognitive Impairment in a Memory Clinic Population: Rationale and Design of the “Utrecht-Amsterdam Clinical Features and Prognosis in Vascular Cognitive Impairment” (TRACE-VCI) Study
por: Boomsma, Jooske Marije Funke, et al.
Publicado: (2017)

Lower cerebral blood flow in subjects with Alzheimer's dementia, mild cognitive impairment, and subjective cognitive decline using two-dimensional phase-contrast magnetic resonance imaging
por: Leijenaar, Jolien F., et al.
Publicado: (2017)

The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial
por: Prins, Niels D, et al.
Publicado: (2014)

Acute response to cholinergic challenge predicts long‐term response to galantamine treatment in patients with Alzheimer's disease
por: Baakman, Anne Catrien, et al.
Publicado: (2022)

Design of the ExCersion-VCI study: The effect of aerobic exercise on cerebral perfusion in patients with vascular cognitive impairment
por: Leeuwis, Anna E., et al.
Publicado: (2017)

Microbleeds are associated with depressive symptoms in Alzheimer's disease
por: Leeuwis, Anna E., et al.
Publicado: (2017)

Safety, pharmacokinetics, and pharmacodynamics of Gln‐1062, a prodrug of galantamine
por: Bakker, Charlotte, et al.
Publicado: (2020)

First in human study with a prodrug of galantamine: Improved benefit-risk ratio?
por: Baakman, Anne C., et al.
Publicado: (2016)

Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer’s disease
por: Benedictus, Marije R., et al.
Publicado: (2016)

Small vessel disease lesion type and brain atrophy: The role of co‐occurring amyloid
por: Heinen, Rutger, et al.
Publicado: (2020)

Sex differences in memory clinic patients with possible vascular cognitive impairment
por: Exalto, Lieza G., et al.
Publicado: (2020)

Trends and highlights of VCI 2004
por: Fabjan, Christian Wolfgang, et al.
Publicado: (2004)

Progress on large area GEMs (VCI 2010)
por: Villa, Marco, et al.
Publicado: (2010)

Gray matter T1‐w/T2‐w ratios are higher in Alzheimer's disease
por: Pelkmans, Wiesje, et al.
Publicado: (2019)

RPC Plots for Vienna Conference VCI
por: CMS Collaboration
Publicado: (2013)

Vienna Conference on Instrumentation (VCI 2022)
por: Collective
Publicado: (2022)

Biperiden Challenge Model in Healthy Elderly as Proof‐of‐Pharmacology Tool: A Randomized, Placebo‐Controlled Trial
por: Bakker, Charlotte, et al.
Publicado: (2021)

Grey matter network trajectories across the Alzheimer’s disease continuum and relation to cognition
por: Dicks, Ellen, et al.
Publicado: (2020)

Amsterdam Dementia Cohort: Performing Research to Optimize Care
por: van der Flier, Wiesje M., et al.
Publicado: (2018)

Grey matter network markers identify individuals with prodromal Alzheimer’s disease who will show rapid clinical decline
por: Pelkmans, Wiesje, et al.
Publicado: (2022)

Trigger Detectors for the LHCb Muon System VCI 2001
por: Riegler, W
Publicado: (2001)

Trigger detectors for the LHCb muon system VCI 2001
por: Riegler, W
Publicado: (2002)

Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease
por: Dicks, Ellen, et al.
Publicado: (2019)

Performances of an electromagnetic calorimeter prototype for the ALICE experiment VCI 2001
por: Arnaldi, R, et al.
Publicado: (2000)

Extended theorems for signal induction in particle detectors VCI 2004
por: Riegler, Werner
Publicado: (2004)

Extended theorems for signal induction in particle detectors VCI 2004
por: Riegler, W
Publicado: (2004)

Vascular cognitive impairment (VCI): Progress towards knowledge and treatment
por: Legge, Silvia Di, et al.
Publicado: (2010)

VCI-Based Analysis on Spatiotemporal Variations of Spring Drought in China
por: Liang, Liang, et al.
Publicado: (2021)

Galantamine ameliorates experimental pancreatitis
por: Thompson, Dane A., et al.
Publicado: (2023)

Association of Education and Intracranial Volume With Cognitive Trajectories and Mortality Rates Across the Alzheimer Disease Continuum
por: van Loenhoud, Anna C., et al.
Publicado: (2022)

Cerebral Blood Flow and Cognitive Functioning in a Community-Based, Multi-Ethnic Cohort: The SABRE Study
por: Leeuwis, Anna E., et al.
Publicado: (2018)

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment
por: ten Kate, Mara, et al.
Publicado: (2017)

Validation of NINDS-VCI Neuropsychology Protocols for Vascular Cognitive Impairment in Taiwan
por: Lin, Hsiu-Fen, et al.
Publicado: (2016)

Birth, expansion, and death of VCY-containing palindromes on the human Y chromosome
por: Shi, Wentao, et al.
Publicado: (2019)

EGb in the Treatment for Patients with VCI: A Systematic Review and Meta-Analysis
por: Zhan, Min, et al.
Publicado: (2021)

MRI Visual Ratings of Brain Atrophy and White Matter Hyperintensities across the Spectrum of Cognitive Decline Are Differently Affected by Age and Diagnosis
por: Rhodius-Meester, Hanneke F. M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2uts660c53m6ugmk9lqj7qsimn